ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28

Nature

Volumn 402, Issue Suppl 6763, 1999, Pages 21-24

  Hutloff, Andreas ^a   Dittrich, Anna M ^a   Beier, Katja C ^a   Eljaschewitsch, Barbara ^a   Kraft, Regine ^b   Anagnostopoulos, Ionnis ^c   Kroczek, Richard A ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

^b Department of Protein Chemistry Max Delbrck Centrum ^*  (Germany)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84891559837     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/35005523     Document Type: Article

References (31)

1. T. Hara S.M. Fu J.A. Hansen Human T cell activation. II. A new activation pathway used by a major T cell population via a disulfide-bonded dimer of a 44 kilodalton polypeptide (9.3 antigen). J. Exp. Med. 1985 161 1513 1524 1:CAS:528:DyaL2MXksFagurY%3D 10.1084/jem.161.6.1513 3159820
2. A. Shahinian Differential T cell costimulatory requirements in CD28-deficient mice. Science 1993 261 609 612 1993Sci..261.609S 1:CAS:528:DyaK3sXltlOjs7Y%3D 10.1126/science.7688139 7688139
3. P.J. Lucas I. Negishi K. Nakayama L.E. Fields D.Y. Loh Naive CD28-deficient T cells can initiate but not sustain an in vitro antigen-specific immune response. J. Immunol. 1995 154 5757 5768 1:CAS:528:DyaK2MXlvVWgt7g%3D 7751626
4. D.J. Lenschow T.L. Walunas J.A. Bluestone CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 1996 14 233 258 1:CAS:528:DyaK28XitlCgtLo%3D 10.1146/annurev.immunol.14.1.233 8717514
5. C.A. Chambers J.P. Allison Co-stimulation in T cell responses. Curr. Opin. Immunol. 1997 9 396 404 1:CAS:528:DyaK2sXktlCgsbs%3D 10.1016/S0952-7915(97)80087-8 9203422
6. T.L. Walunas CTLA-4 can function as a negative regulator of T cell activation. Immunity 1994 1 405 413 1:CAS:528:DyaK2cXmt1yhurw%3D 10.1016/1074-7613(94)90071-X 7882171
7. E. Tivol Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 1995 3 541 547 1:CAS:528:DyaK2MXps1Oqtrw%3D 10.1016/1074-7613(95)90125-6 7584144
8. P. Waterhouse Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 1995 270 985 988 1995Sci..270.985W 1:CAS:528:DyaK2MXptlOlurk%3D 10.1126/science.270.5238.985 7481803
9. C.B. Thompson J.P. Allison The emerging role of CTLA-4 as an immune attenuator. Immunity 1997 7 445 450 1:CAS:528:DyaK2sXntVSlsLY%3D 10.1016/S1074-7613(00)80366-0 9354465
10. J.F. Brunet Anew member of the immunoglobulin superfamily — CTLA-4. Nature 1987 328 267 270 1987Natur.328.267B 1:CAS:528:DyaL2sXmtFaktL0%3D 10.1038/328267a0 3496540
11. R.J. Peach Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1. J. Exp. Med. 1994 180 2049 2058 1:CAS:528:DyaK2cXmsFehtrk%3D 10.1084/jem.180.6.2049 7964482
12. A. Truneh Differential recognition by CD28 of its cognate counter receptors CD80 (B7.1) and B70 (B7.2): analysis by site directed mutagenesis. Mol. Immunol. 1996 33 321 334 1:CAS:528:DyaK28Xjtl2ntb8%3D 10.1016/0161-5890(95)00077-1 8649453
13. J. Nunes CD28 mAbs with distinct binding properties differ in their ability to induce T cell activation: analysis of early and late activation events. Int. Immunol. 1993 5 311 315 1:CAS:528:DyaK2cXlt1agtw%3D%3D 10.1093/intimm/5.3.311 8385476
14. C.B. Thompson CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines. Proc. Natl Acad. Sci. USA 1989 86 1333 1337 1989PNAS..86.1333T 1:CAS:528:DyaL1MXhtlehtLw%3D 10.1073/pnas.86.4.1333 2465550 286684
15. R.A. Kroczek Defective expression of CD40 ligand on T cells causes “X-linked immunodeficiency with hyper-IgM (HIGM1)”. Immunol. Rev. 1994 138 39 59 1:CAS:528:DyaK2cXkvVSnsbw%3D 10.1111/j.1600-065X.1994.tb00846.x 7915248
16. I.C. MacLennan Germinal centers. Annu. Rev. Immunol. 1994 12 117 139 1:CAS:528:DyaK2cXivFKjurk%3D 10.1146/annurev.iy.12.040194.001001 8011279
17. V.K. Tsiagbe G. Inghirami G.J. Thorbecke The physiology of germinal centers. Crit. Rev. Immunol. 1996 16 381 421 1:STN:280:DyaK2s7ht1GktA%3D%3D 8954256
18. M.F. Krummel J.P. Allison CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 1996 183 2533 2540 1:CAS:528:DyaK28XjslaisL0%3D 10.1084/jem.183.6.2533 8676074
19. T.L. Walunas C.Y. Bakker J.A. Bluestone CTLA-4 ligation blocks CD28-dependent T cell activation. J. Exp. Med. 1996 183 2541 2550 1:CAS:528:DyaK28XjslaisLo%3D 10.1084/jem.183.6.2541 8676075
20. K. Nakanishi Both interleukin 2 and a second T cell-derived factor in EL-4 supernatant have activity as differentiation factors in IgM synthesis. J. Exp. Med. 1984 160 1605 1621 1:CAS:528:DyaL2MXmtVGntg%3D%3D 10.1084/jem.160.6.1605 6439814
21. L.K. Jung T. Hara S.M. Fu Detection and functional studies of p60-65 (Tac antigen) on activated human B cells. J. Exp. Med. 1984 160 1597 1602 1:STN:280:DyaL2M%2Fjt1Ggsw%3D%3D 10.1084/jem.160.5.1597 6092512
22. F. Rousset Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl Acad. Sci. USA 1992 89 1890 1893 1992PNAS..89.1890R 1:CAS:528:DyaK38Xhslajtr4%3D 10.1073/pnas.89.5.1890 1371884 48559
23. V. Kindler R.H. Zubler Memory, but not naive, peripheral blood B lymphocytes differentiate into Ig-secreting cells after CD40 ligation and costimulation with IL-4 and the differentiation factors IL-2, IL-10, and IL-3. J. Immunol. 1997 159 2085 2090 1:CAS:528:DyaK2sXlslGls7k%3D 9278293
24. J. Choe Y.S. Choi IL-10 interrupts memory B cell expansion in the germinal center by inducing differentiation into plasma cells. Eur. J. Immunol. 1998 28 508 515 1:CAS:528:DyaK1cXhsFGgsL8%3D 10.1002/(SICI)1521-4141(199802)28:02<508::AID-IMMU508>3.0.CO;2-I 9521060
25. C. Schneider R.A. Newman D.R. Sutherland U. Asser M.F. Greaves Aone-step purification of membrane proteins using a high efficiency immunomatrix. J. Biol. Chem. 1982 257 10766 10769 1:CAS:528:DyaL38XlsFyqu70%3D 6955305
26. J. Rosenfeld J. Capdevielle J.C. Guillemot P. Ferrara In-gel digestion of proteins for internal sequence analysis after one- or two-dimensional gel electrophoresis. Anal. Biochem. 1992 203 173 179 1:CAS:528:DyaK38Xkt1aksbg%3D 10.1016/0003-2697(92)90061-B 1524213
27. K.A. Jacobs The thermal stability of oligonucleotide duplexes is sequence independent in tetraalkylammonium salt solutions: application to identifying recombinant DNA clones. Nucleic Acids Res. 1988 16 4637 4650 1:CAS:528:DyaL1cXktlequ74%3D 10.1093/nar/16.10.4637 3380691 336654
28. A. Aruffo B. Seed Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system. Proc. Natl Acad. Sci. USA 1987 84 8573 8577 1987PNAS..84.8573A 1:CAS:528:DyaL1cXhs1alsrc%3D 10.1073/pnas.84.23.8573 2825196 299587
29. A.F. Williams A.N. Barclay The immunoglobulin superfamily — domains for cell surface recognition. Annu. Rev. Immunol. 1988 6 381 405 1:CAS:528:DyaL1cXitF2qt7g%3D 10.1146/annurev.iy.06.040188.002121 3289571
30. J.L. Cordell Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J. Histochem. Cytochem. 1984 32 219 229 1:CAS:528:DyaL2cXotlyiuw%3D%3D 10.1177/32.2.6198355 6198355
31. Prediction of transmembrane helices in proteins [online] (cited 01 Dec. 98)〈www.cbs.dtu.dk/services/TMHMM-1.0/〉 ((1998)).